ISSN 0100-879X
CLINICAL INVESTIGATION
www.bjournal.com.brwww.bjournal.com.br
Volume 43 (6) 522-599 June 2010
Faculdade de Medicina
de Ribeirão Preto
Campus
Ribeirão Preto
Institutional Sponsors
The Brazilian Journal of Medical and Biological Research is partially financed by
analiticaweb.com.br S C I E N T I F I C
Hotsite of proteomics metabolomics
developped by:
Braz J Med Biol Res, June 2010, Volume 43(6) 537-542
doi: 10.1590/S0100-879X2010005000009
Occupational therapy in spinocerebellar ataxia type 3: an
open-label trial
R.C.R. Silva, J.A.M. Saute, A.C.F. Silva, A.C.O. Coutinho, M.L. Saraiva-Pereira and L.B. Jardim
www.bjournal.com.br Braz J Med Biol Res 43(6) 2010
Brazilian Journal of Medical and Biological Research (2010) 43: 537-542
ISSN 0100-879X
Occupational therapy in spinocerebellar
ataxia type 3: an open-label trial
R.C.R. Silva1,4, J.A.M. Saute5, A.C.F. Silva5, A.C.O. Coutinho4,
M.L. Saraiva-Pereira1,2,5 and L.B. Jardim1,3,5
1Programa de Pós-Graduação em Ciências Médicas, 2Departamento de Bioquímica,
3Departamento de Medicina Interna, Universidade Federal do Rio Grande do Sul,
Porto Alegre, RS, Brasil
4Serviço de Reabilitação, 5Serviço de Genética Médica, Hospital de Clínicas de Porto Alegre,
Porto Alegre, RS, Brasil
Abstract
Occupational therapy (OT) is a profession concerned with promoting health and well-being through occupation, by enabling
handicapped people to participate in the activities of everyday life. OT is part of the clinical rehabilitation of progressive genetic
neurodegenerative diseases such as spinocerebellar ataxias; however, its effects have never been determined in these diseases.
Our aim was to investigate the effect of OT on both physical disabilities and depressive symptoms of spinocerebellar ataxia type
3 (SCA3) patients. Genomically diagnosed SCA3 patients older than 18 years were invited to participate in the study. Disability,
as evaluated by functional independence measurement and Barthel incapacitation score, Hamilton Rating Scale for Depression,
and World Health Organization Quality of Life questionnaire (WHOQOL-BREF), was determined at baseline and after 3 and
6 months of treatment. Twenty-six patients agreed to participate in the study. All were treated because OT prevents blinding
of a control group. Fifteen sessions of rehabilitative OT were applied over a period of 6 months. Difficult access to food, cloth-
ing, personal hygiene, and leisure were some of the main disabilities focused by these patients. After this treatment, disability
scores and quality of life were stable, and the Hamilton scores for depression improved. Since no medication was started up
to 6 months before or during OT, this improvement was related to our intervention. No association was found between these
endpoints and a CAG tract of the MJD1 gene (CAGn), age, age of onset, or neurological scores at baseline (Spearman test).
Although the possibly temporary stabilization of the downhill disabilities as an effect of OT remains to be established, its clear
effect on depressive symptoms confirms the recommendation of OT to any patient with SCA3 or spinocerebellar ataxia.
Key words: Spinocerebellar ataxia 3; Occupational therapy; Rehabilitation; Depression; Machado-Joseph disease;
Polyglutamine diseases
Introduction
Correspondence: L.B. Jardim, Serviço de Genética Médica, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350,
90035-903 Porto Alegre, RS, Brasil. E-mail: ljardim@hcpa.ufrgs.br
Received August 11, 2009. Accepted March 2, 2010. Available online April 16, 2010. Published June 11, 2010.
Spinocerebellar ataxia 3 (SCA3), also known as Macha-
do-Joseph disease, is a rare neurodegenerative disease
caused by expansions of a CAG tract of the MJD1 gene
(1-3). The expanded allele is dominant, and there is an
important correlation of the repeat amplification with both
symptom severity and age at onset in affected individuals.
There is no treatment.
SCA3 affects at least 3:100,000 individuals in the Brazil-
ian population (4). SCA3 is a highly disabling disease, which
imposes a severe burden on the patients and their families.
Clinical manifestations usually start during adulthood, with
a mean (± SD) age at onset of 32 ± 12 years (5). Patients
end up confined to a wheelchair and later become bedrid-
den (6). Age at onset distribution is very wide and ranges
between 5 and 73 years (6). Median survival time after onset
is 21 years (7).
The disease is related to neuronal loss and neuronal
intranuclear inclusions, detected mainly in the dentate
nucleus of the cerebellum, the nucleus dorsalis of Clarke in
the spinal cord, cranial motor nerve nuclei, pontine nuclei,
substantia nigra, and the lenticular fasciculus of the globus
pallidus (8-11). Clinical manifestations usually start with
cerebellar ataxia affecting gait, limb movements, speech
articulation, and deglutition. Patients also present a variety
of other dysfunctions, including pyramidal involvement; a
supranuclear, progressive external ophthalmoplegia with
538 R.C.R. Silva et al.
www.bjournal.com.brBraz J Med Biol Res 43(6) 2010
limitation of upward gaze and convergence; extrapyramidal
signs, including dystonia, rigidity, bradykinesia, and even a
full parkinsonian syndrome; lower motor neuron disease,
with fasciculation and amyotrophy; sensitive loss; eyelid
retraction, contraction fasciculation, weight loss, and sleep
disorder (6). All of these findings lead to a progressive bur-
den and incapacitation. In addition, depressive symptoms
are rather frequent and may be related to the inexistence
of an effective treatment (12). In SCA3, depressive scores
have been associated with the level of incapacitation,
conditions that probably reinforce each other.
To our knowledge, very few studies of rehabilitation inter-
ventions in SCAs in general and in SCA3 in particular have
appeared in the literature. Among rehabilitation techniques,
occupational therapy (OT) aims to adapt a particular patient
to the activities of his/her daily living in order to obtain the
maximum possible independence. OT is a common clinical
practice, although its effects have never been measured
in patients with SCA. In order to identify the role of OT in
SCA3, the present study describes the disabilities associ-
ated with the disease, the effect of occupational therapy on
these disabilities, on depressive symptoms and on quality
of life, and the possible associations of these endpoints
with risk factors, such as a CAG tract of the MJD1 gene
(CAGn) and age of onset.
Material and Methods
Genomically diagnosed SCA3 patients older than 18
years were invited to participate. The inclusion criterion
was independent gait on neurological examination. Patients
who had started any therapy less than 6 months before or
who had previously been on OT were excluded. The pres-
ent study was approved by the Grupo de Pesquisa e de
Pós-Graduação do Hospital de Clínicas de Porto Alegre
(GPPG, process #05-254), and all patients gave written
informed consent before participating.
After the patients agreed to participate in the study, a
structured interview, which included four instruments to
measure endpoints, was performed. The disability scores
included the functional independence measurement (FIM)
in its Portuguese version (13,14), and Barthel Incapacitation
scores (15). FIM scores were classified as follows: under
18, total dependence; 18 to 60, 50% dependence; 61 to
103, 25% dependence, and over 104, preserved indepen-
dence. Barthel scores were classified as follows: 0 to 45,
severe motor disability; 46 to 75, moderate disability; 76
to 99, mild disability, and 100, no disability. Depressive
symptoms were measured by the Hamilton Rating Scale
for Depression (16). Scores over 25, between 18 and
24, and between 17 and 7 were associated with severe,
moderate and mild depression, respectively. Quality of
life was investigated with the Portuguese version of the
World Health Organization Quality of Life questionnaire
(WHOQOL-BREF) (17,18). At baseline, the Neurological
Examination Score for Spinocerebellar Ataxia (NESSCA)
(19) and the Scale for Assessment and Rating of Ataxia
(SARA) score (20) were performed by previously trained
observers (JAMS and ACFS).
The OT frame of reference followed the rehabilitative
(compensatory) model (21). OT intervention consisted of
weekly sections of 40 min during the first 3 months, followed
by monthly sections during another 3 months. In the first
interview, the most significant functional limitations in the pa-
tient’s life were identified according to patient’s opinion. The
following items were considered: access to food, clothing,
bathroom use, and personal hygiene; important activities
for the individual’s economic support; leisure activities, and
the ways the patient interacts and meets with his/her social
and affective circles. Both patient and occupational therapist
elected priorities, including viable objectives only. As a result,
the patient and the therapist agreed upon a practical plan;
if necessary, modifications were made during follow-up.
In short, interventions followed the clinical practice of OT.
The endpoint instruments were applied again at 3 and 6
months after the beginning of OT treatment. Patients were
maintained thereafter on bi-monthly follow-ups.
Hamilton, Barthel, FIM, and WHOQOL scores (the
endpoints) at baseline and after either 3 or 6 months on OT
were compared using the paired Student t-test if variables
showed normal distribution; baseline scores were compared
with the final scores of the same individual. Non-parametric
variables were tested by the Wilcoxon U-test or the Kruskal-
Wallis test. Possible associations between endpoints were
tested using the Spearman correlation test. Correlations
were also tested between endpoints and the following risk
factors by the Spearman test: age, age of onset, CAGn,
NESSCA, and SARA scores. Bonferroni corrections were
made due to the use of multiple tests. The level of signifi-
cance was set at 0.05.
Results
Twenty-six individuals entered the study. They all had
the same geographical and urban origin and lived in Rio
Grande do Sul, Brazil, where SCA3 cases seem to be lim-
ited to persons of Azorean ancestry and moreover to the
ancestral haplotype A-C-A (22). Their clinical and genomic
characteristics are summarized in Table 1. The group of
patients showed on average mild depressive symptoms.
The disability scores of these patients were also mild,
although neurological findings were substantial (NESSCA
and SARA). Quality of life was on average moderately
compromised, and there was no skewness of the results.
Three individuals were lost to follow-up: 1 patient did
not return to the third monthly visit, and the other 2 patients
did not return at the end of the study. Age, schooling, and
baseline NESSCA, SARA, FIM, Barthel, and Hamilton
scores were similar for both the lost and remaining patients.
Although non-significant, losses showed a trend towards
Occupational therapy for SCA3 539
www.bjournal.com.br Braz J Med Biol Res 43(6) 2010
having a longer CAGn when compared
to the general sample (78 vs 74) and
consequently earlier ages at onset
(28.6 ± 13.3 vs 37.1 ± 10 years). The
quality of life of cases lost to follow-up
also tended to be worse than that of
the general group (45.8 ± 14.4 vs 58.1
± 9.6; P = 0.06).
Follow-up of depressive
symptoms
Hamilton scores (mean ± SD) for
depression obtained for the 23 patients
who completed the study were 8.65 ±
6.6 and 6.04 ± 6.2 before and after 6
months of OT treatment, respectively.
This improvement was not only signifi-
cant (P < 0.0001, paired t-test), but the
mean (after trial) also reached normal
values. Individual scores are presented
in Figure 1.
The difference between the 6th month score and baseline
score, hereafter referred to as ∆ Hamilton, was not related
to the independent variables under study (age, age at onset,
schooling, CAGn, SARA, and NESSCA scores) or to the
other endpoints measured (Barthel, WHOQOL, and FIM) at
baseline or at the patients own progression slopes.
Individuals with higher depressive scores at baseline
showed apparently better responses to treatment (OT) after
6 months (Figure 2A; r = -0.619, P < 0.002, Spearman).
Follow-up of FIM and Barthel scores for disability
The incapacities most referred to by patients were
Figure 1. Progression of Hamilton Depression Scores for each
individual under trial. Scores were obtained at baseline and after
3 and 6 months on occupational therapy.
Figure 2. Relation between baseline scores and response after 6 months on occupational therapy of (A) Hamilton Depression Rat-
ing Scale and (B) Barthel Incapacitation scores. In both graphs, the x-axis represents the difference between the 6 months and the
baseline scores.
Table 1. Characteristics of the sample studied.
Characteristics Normal range
Male gender (total) 14 (26)
Age (years) 42.4 ± 10 (22-56)
Age at onset (years) 36.15 ± 10.6 (14-56)
Disease duration (years) 5 ± 0.79 (0.5-15)
Expanded CAG 73 ± 0.77 (68-82)
NESSCA 0-1 14.8 ± 4.8 (6-27)
SARA 0 10.6 ± 4.3 (3-19)
Measure of functional incapacity (18 → 126) 104 to 126 120.19 ± 4.6 (104-126)
Barthel (0 → 100) 100 97 ± 5.6 (75-100)
Hamilton (52 → 0) Up to 7 8.54 ± 6.3 (0-26)
WHOQOL (0 → 100) 56.7 ± 10.7 (38-75)
Data are reported as means ± SD with range within parentheses except for disease du-
ration and expanded CAG, which are reported as median ± SEM. NESSCA = Neurologi-
cal Examination Score for Spinocerebellar Ataxia; SARA = Scale for Assessment and
Rating of Ataxia; WHOQOL = World Health Organization Quality of Life questionnaire.
540 R.C.R. Silva et al.
www.bjournal.com.brBraz J Med Biol Res 43(6) 2010
difficulty in dynamic balance resulting in walking deficits,
difficulty in word articulation, and difficulty in handling
tableware and pens.
Mean ± SD scores for disability did not change after 6
months of OT: FIM scores were 120.17 ± 4.8 and 120.26
± 6.5, and Barthel scores were 96.9 ± 5.9 and 96.9 ±
6.3 at baseline and after 6 months. When the group was
stratified according to CAGn (two groups of patients, with
cut-off at 73 CAGs) and to disease duration (cut-off at 5
years of disease duration), no differences were found in
FIM progression.
Some individuals actually got worse after 6 months of
follow-up. Regarding Barthel scores, an inverse relation was
observed between response (∆ Barthel) and baseline; the
better the baseline, the worse the response after 6 months.
This phenomenon is illustrated in Figure 2B.
Follow-up of quality of life
Mean ± SD scores of global WHOQOL did not change
after 6 months of OT; they were 58.1 ± 9.6 and 58.1 ± 14.4
at baseline and after 6 months (paired t-test). Since patients
lost to follow-up tended to have worse WHOQOL and in order
to test if their exclusion could have biased these results,
we also compared the WHOQOL of the overall sample at
baseline (26 cases) to that of the remaining sample at 6
months (23 cases). No differences were found.
Actually, 4 patients improved according to WHOQOL,
15 remained the same, and 4 worsened at the end of ob-
servation. When these three subgroups were analyzed, no
differences were found in their independent variables or in
the other endpoints studied.
Discussion
OT is currently part of common clinical practice, although
its effects have rarely been measured. Since interventions
are individually tailored in any rehabilitation therapy but
especially in OT, the variability of interventions or their
qualitative nature can partially explain the lack of studies
on their effects. OT is particularly important in progressively
incapacitating diseases, especially those without any known
treatment. The objective of OT is to improve abilities and
capacities of daily living in handicapped individuals. And due
to the progressive nature of neurodegenerative diseases,
OT should not only be a permanent management but also
change as disease progresses.
Studies on the impact of OT on SCAs in general are
lacking. Two open-label trials on SCA2 studied the impact
of physical training and of group psychotherapy (23,24).
Both studies reported favorable follow-ups, but interven-
tion, disease under study and endpoints were diverse, and
therefore their results are hardly comparable to ours. Expert
opinions are also rare: in a review article, neuroanatomi-
cal characteristics were analyzed regarding rehabilitative
choices in SCA2 and SCA3 (25).
Since we routinely indicate OT to our patients, we tried
to improve our knowledge about the role of this rehabilitation
technique. Our challenge started when we tried to figure
out what the specific effect of OT would be, for instance,
on capacities and abilities, social adaptation, or personal
adaptation to the disease. The existing instruments used to
measure these endpoints are multiple, and there is no unique
severity score with all these domains. Because of this, we
decided to test disabilities, quality of life, and depressive
manifestations. Our second challenge was the study design,
and we decided for an open trial. This design was chosen for
two main reasons. First, OT is an acclaimed management,
which is no longer prone to randomized studies. Second,
blinding OT would be rather impossible.
Our results indicate that OT improved the Hamilton
scores for depression of SCA3 patients. This response to
OT was not related to the independent variables under study,
i.e., gender, age, age at onset, schooling, CAGn, NESSCA,
and SARA scores. Moreover, improvement of depression
did not correlate with the other endpoints.
Incapacitation scores - Barthel score and FIM - and
quality of life were stable throughout this study. However,
since the natural history of these parameters in SCA3 is
unknown, interpretation of these data was not possible. This
is a drawback of this study design, where no control group
was monitored. When the natural history of a progressive
disorder like SCA3 is unknown, open trials do not allow
stabilizations to be interpreted as positive results. Stable
states may theoretically be related to the natural course of a
disease. Only improvements can be seen as definite results
of open trials, in relentless diseases like SCA3.
Although the paired t-test did not detect any statistically
significant differences in Barthel or FIM after 6 months of
observation, a careful exam of the data revealed a sad
reality. Baseline Barthel had an inverse correlation with
responses, or ∆. In other words, patients with the best
functional independence parameters at the beginning of the
study tended to get worse after 6 months. This was clearly
the result of the natural course of the disease.
The observation started with 26 cases; 3 dropped out,
but there was apparently no bias due to these losses. In any
case, it is possible that patients with more social networks
and consequently better quality of life were inadvertently
selected. Keeping in mind that this sample was limited
to independent ambulatory patients, we still believe that
this group was representative of SCA3 patients with an
A-C-A ancestry, since general parameters such as age,
age at onset, gender, CAGn ranges, and NESSCA scores
were similar to those found in previous studies on these
populations (5,19).
OT improved the depressive symptoms of SCA3 pa-
tients, which are an important clinical problem already
shown to be common among these patients (12). Organic
or reactive depressive symptoms can affect 33.5% of SCA3
individuals. The relation between depressive scores and
Occupational therapy for SCA3 541
www.bjournal.com.br Braz J Med Biol Res 43(6) 2010
incapacitation leve